Lung Cancer Voices

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Tony Mok, Li Shu Fan Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong, to break down some of the biggest lung cancer highlights from the 2026 ASCO Conference, held in Chicago this June. Together, they discuss new research on targeted treatment after surgery for RET-positive lung cancer, immunotherapy...

Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec le Dr Nicolas Marcoux, hémato-oncologue au CHU Hôtel Dieu de Québec, afin de mieux comprendre le rôle des biomarqueurs et des tests moléculaires dans le traitement du cancer du poumon. Ensemble, ils expliquent pourquoi ces analyses sont essentielles pour orienter les choix de traitement, comment les thérapies ciblées et les biopsies liqui...

In this episode, Dr. Paul Wheatley-Price speaks to Dr. Ross Camidge, our guest in this increidbly unique episode of "Perspectives", sharing his leading clinical expertise on the treatment of EGFR-positive lung cancer as Director of the Thoracic Oncology at the University of Colorado Cancer Center. On the other hand, being diagnosed with the same disease himself at stage 4 in 2022, Dr. Camidge shar...

La Dre Nathalie Daaboul s’entretient avec Eva dans cet épisode, qui raconte son parcours après un diagnostic de cancer du poumon reçu en janvier 2020, alors qu’elle menait une vie active et faisait déjà un effort important pour prendre soin de sa santé. Elle partage son expérience avec la radiothérapie et l’immunothérapie, l’importance d’être à l’écoute de son corps, ainsi que la façon dont le can...

In this episode, Dr. Paul Wheatley-Price talks to Dr. Sara Moore about her work and experience in caring for Inuit populations in Nunavut affected by lung cancer. What is the scope of the populations she treats, the unique access barriers for diagnostics and treatment, and how their lung cancer experiences may differ than those living in Southern Canada. Dr. Moore is an Assistant Professor at Univ...

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Arielle Elkrief, oncologue et chercheuse-clinicienne, co-directrice du Centre de microbiome du CHUM, sur le rôle fascinant du microbiome intestinal dans la lutte contre le cancer. Qu'est-ce que le microbiome exactement, comment se développe-t-il au fil de notre vie, quels facteurs peuvent le perturber, quel est son lien avec l'immu...

In today's episode, Dr. Paul Wheatley-Price chats with Dr. Natasha Leighl, Medical Oncologist and Lung Site Lead at the Princess Margaret Cancer Center in Toronto, all about liquid biopsies. What is a biopsy, the difference between a tissue vs liquid biopsy, how does it work, when it can be done, and where is it available in Canada? Dr. Leighl gets into all the details with her renowned expertise...

In this episode, Dr. Paul Wheatley-Price speaks with Dr. Christian Finley, Co-Chair of the Pan-Canadian Lung Cancer Action Plan Steering Committee and Professor at McMaster University. They explore the newly released 2026–2035 Pan-Canadian Lung Cancer Action Plan - an ambitious national roadmap to reduce lung cancer deaths by 30% over the next decade. Lung Cancer Canada has been actively involved...

Dans cet épisode, Dre Nathalie Daaboul s’entretient avec Mme Annick Dufour, pharmacienne en oncologie à l'Hôpital Charles-Le Moyne à Montreal, à propos du rôle essentiel des pharmaciens dans la prise en charge du cancer du poumon. Ensemble, elles expliquent en quoi consiste la pharmacie en oncologie, comment les pharmaciens collaborent avec l’équipe médicale, et leur rôle dans la préparation, la v...

In this episode, Dr. Paul Wheatley-Price chats with Dr. Ines Menjak, Medical Oncologist at Sunnybrook Health Sciences Centre in Toronto, about the 2026 landscape of immunotherapy treatment for lung cancer. What exactly is immunotherapy, how does it work, when is it used, common side effects to expect, what are the latest drugs, and what's coming down the pipeline.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Lisa Hicks, a hematologist-oncologist at St. Michael’s Hospital, who specializes in caring for medically and socially complex people with blood cancer. They talk about the unique neighbourhood that she serves in downtown Toronto, what are the social determinants of health, how various aspects of poverty and societal inequity might impact thos...

Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec la Dre Myriam Bouchard, radio-oncologue au Centre Hospitalier Universitaire de Sherbrooke, afin de démystifier la radiothérapie dans le traitement du cancer du poumon. Ensemble, elles expliquent quand et pourquoi la radiothérapie est utilisée, les avancées qui rendent les traitements plus précis et mieux tolérés, comment les effets second...

In our second episode of the "Perspectives" series, Dr. Paul Wheatley-Price chats with two guests, both with a depth of experience in ROS1+ lung cancer, a rare subtype of non-small cell lung cancer (NSCLC) which represents only about 1-2% of all lung cancer cases in Canada. Rev. Richard Reimer from Edmonton shares his story being diagnosed in 2009 with stage 4 lung cancer that was later identified...

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Catherine Labbé, pneumologue spécialisée en oncologie pulmonaire à l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), au sujet de tout ce qu'il faut savoir sur le dépistage du cancer du poumon : qui est admissible, quels sont les critères et pourquoi est-il important de se faire dépister si vous présentez...

In our new series called Perspectives on Lung Cancer, Dr. Paul Wheatley-Price sits down with two guests, both with a depth of experience in ALK+ lung cancer, which represents about 4-8% of all lung cancer cases in Canada. Dr. Cheryl Ho, medical oncologist at BC Cancer, provides her perspective as a physician treating these types of cancers in her daily practice, while Katie Hulan shares her journe...

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec le Dr Kevin Jao, coprésident du comité médical consultatif de Cancer pulmonaire Canada et hémato-oncologue à l'Hôpital du Sacré-Cœur-de-Montréal. Ils présentent Cancer pulmonaire Canada, tout le soutien et les ressources disponibles pour les Canadiens touchés par le cancer du poumon, et mettent particulièrement l'accent sur le Mois de la...

In this episode, Dr. Paul Wheatley-Price is back for our annual recap of the IASLC 2025 World Conference on Lung Cancer (WCLC), which took place in Barcelona, Spain in early September. He is joined by two special guests: Dr. Barbara Melosky, Professor of Medicine at UBC and Medical Oncologist at BC Cancer, and Dr. Peter Ellis, Professor of Oncology at McMaster University and Medical Oncologist at...

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec Lise Boilard, qui a reçu un diagnostic de cancer du poumon en 2017 à l'âge de 44 ans, et sa médecin traitante, la Dre Myriam Bouchard, radio-oncologue au Centre hospitalier de l'université de Sherbrooke. Lise partage son parcours inspirant face au cancer du poumon, la relation unique qu'elles ont nouée ensemble, ainsi que l'expertise du D...

In this episode, Dr. Paul Wheatley-Price chats with Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug appro...

In this episode, Dr. Paul Wheatley-Price chats with Dr. Arielle Elkrief, Medical Oncologist, Co-Director of the CHUM Microbiome Center, and Clinician-Scientist at the University of Montreal. They discuss everything about the microbiome and gut health - what is the microbiome, why it's important in cancer and treatments, tips for a healthy microbiome, antibiotics, and even "poop pills".

In this episode, Dr. Paul Wheatley-Price is back for another update into all the newest highlights from recent clinical trials for EGFR-positive lung cancer treatments. Dr. Stephen Liu is the Director of Thoracic Oncology and Professor of Medicine at Georgetown University in Washington, DC, and he co-hosts his own podcast with the IASLC, "Lung Cancer Considered". They are also joined by Emi Bossio...

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Andrew Robinson and Dr. Nathalie Daaboul on all the highlights coming out of this year's 2025 ASCO Conference, held in Chicago back in June. They discuss major developments in treatment for small cell lung cancer (SCLC), updates in immunotherapy, and a couple of unique drugs coming down the pipeline. Dr. Robinson is a Medical Oncologist a...

In this episode, Dr. Paul Wheatley-Price chats with Dr. Adrian Sacher on everything there is to know about KRAS lung cancer. What is KRAS lung cancer, how is it tested, and what it means in terms of treatment options for those who have this subtype of lung cancer. Dr. Adrian Sacher is a Thoracic Medical Oncologist at the Princess Margaret Cancer Centre and Assistant Professor in the Departments of...

In our special 100th episode, Dr. Paul Wheatley-Price reunites with the Current and Past Presidents of Lung Cancer Canada, to take a trip down memory lane on how lung cancer (and LCC) has evolved over the decades, what's happening now, and what's to come in the future! Dr. Paul Wheatley-Price is joined by our new President Dr. Rosalyn Juergens, and Past Presidents Dr. Stephanie Snow and Dr. Natash...

In this episode, Dr. Paul Wheatley-Price chats with Claire Hopkins, Registered Dietician at the Princess Margaret Cancer Center, about all things nutrition and maintaining heathy eating habits for lung cancer patients. What exactly is the role of a dietician vs nutritionist, is sugar really bad for cancer, tips to maintain a healthy appetite, reasons behind weight loss during treatment, and the be...